City of Hope to evaluate Quest Diagnostics' Haystack MRD for guiding patient management in multiple cancers

Join Pharma | Login

	Editorial


	A CURSED SCHEME CALLED PTUAS
	Wednesday, April 15, 2026
	Implementation of the Pharmaceutical Technology Upgradation Assistance Scheme (PTUAS), launched by the Department of Pharmaceuticals (DoP) in 2022, is proving to be a thorn in flesh of the
	Past Editorial...

TODAY'S NEWS


15:00 [IST]	City of Hope to evaluate Quest Diagnostics' Haystack MRD for guiding patient management in multiple cancers
14:00 [IST]	Eli Lilly announces positive results from phase 3 ACHIEVE-4 trial of Foundayo, compared to insulin glargine in adults with type 2 diabetes and obesity or overweight
13:00 [IST]	Galderma launches new Alastin Regenerating Skin Nectar with TriHex+
12:15 [IST]	India emerges as global hub for complex cardiac care with expanding cath labs and expertise: Dr. Sanjay Mehrotra
12:00 [IST]	Bayer announces publication of full results from pivotal phase III OCEANIC-STROKE study of FXIa inhibitor, asundexian in The New England Journal of Medicine
11:00 [IST]	WuXi Biologics receives ISO 13485:2016 Certification, signifies capabilities in drug-device combo product development and manufacturing

more news >>

TOP NEWS


08:00 [IST]	Share of pharma in merchandise exports grew to almost 7 per cent in 2024-25
08:00 [IST]	Pharma traders fume over restrictive labelling norms in new medical device draft rules
08:00 [IST]	PLI schemes, digital adoption, etc to transition India from generic powerhouse to innovation-driven hub: Experts
08:00 [IST]	MDC seeks written reply from Biological E on exemption of Pneubevax 14 from DPCO pricing
08:00 [IST]	Operational realities & global strategy realignment force MNCs to scale back their units in India: Dr Shenoy
08:00 [IST]	Medical devices industry raises concern over draft notification proposing fee for tests

more news >>

YESTERDAY'S NEWS


18:00 [IST]	Ardena opens bioanalytical lab in Somerset to support client studies, strengthen precision medicine development
17:00 [IST]	Herbalife India and IIT Madras ink pact to set-up India's First CoE on plant cell fermentation
14:50 [IST]	University of Liverpool & IISc launch joint seed fund to accelerate innovation in AI, health and space
14:40 [IST]	Max Smart Super Speciality Hospital, Saket to add 400 beds with the launch of new tower
12:45 [IST]	Burnett Homoeopathy brings global summit to British Parliament and Oxford University, strengthening India’s voice in world healthcare
12:30 [IST]	Orbicular and Gland Pharma announce first ANDA approval with CGT for generic infuvite parenteral nutrition injectable in partnership with Apotex

more news >>

INTERVIEW


Haryana DC targets 100% Schedule M compliance in MSME sector through risk-based audits and continuous training
Lalit Kumar Goel, State Drug Controller (SDC) of Haryana

Past Interviews...

	What's New?

BSE Healthcare index dips by 4.5% in first quarter of 2026, BSE Sensex drops by 15.5% silver sulfadiazine 1% cream/ointment atleast 200 gm jar tab. lithium carbonate 300mg donepezil 5 mg+ memantine 5 mg tab dasatinib 50 mg tab

Opinion Poll

Will the introduction of Revised Schedule M by Union Health Ministry solve the issue of quality of Indian drugs?

YesNoCan't Say

View Past Poll

Corporate

Special Features

Features

Chronicle Pharmabiz Specials

Forthcoming Events

TENDERS & PROJECTS

	Tenders & Enquiries
	Pharma Projects

CORPORATE

	Company Profile
	Corporate Results
	Corporate X-ray
	Pharmabiz Studies of Top Companies

US FDA UPDATE

EXPORT & IMPORT

	Drug Export Procedures
	Drug Units With WHO GMP Certification
	Pharma Export Data
	Import Reg. Update

PHARMA LAWS & DOCUMENTS

LIST OF LABS & GOVT. BODIES

	Govt Recognised In-House R&D Units
	AICTE Boards & Committees
	List of Indian CROs
	List of CROs (International)
	Govt & approved labs of India
	List of State Drugs Controllers